• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Allergan Inc. (AGN)

    -NYSE
    232.74 Up 0.34(0.15%) 4:00PM EST
    |After Hours : 234.12 Up 1.38 (0.59%) 7:41PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Allergan Inc.
    2525 Dupont Drive
    Irvine, CA 92612
    United States - Map
    Phone: 714-246-4500
    Fax: 714-246-6987
    Website: http://www.allergan.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:10,500

    Business Summary 

    Allergan, Inc. discovers, develops, and commercializes pharmaceuticals, biologics, medical devices, and over-the-counter products in the Unites States and internationally. It operates through two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including, ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, other prescription, and over-the-counter skin care products; and urology products. The Medical Devices segment provides a range of medical devices comprising breast implants for augmentation, revision, reconstructive surgery, and tissue expanders; and facial aesthetics products. The company also engages in the research and development of various products in ophthalmology, neuromodulators, migraine, urology, medical dermatology, and medical aesthetics. Allergan, Inc. markets and sells its products primarily through its subsidiaries, independent distributors, and regional sales and marketing organizations to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company primarily focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Allergan Inc.

    Corporate Governance 
    Allergan Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 9. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 9; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. David E. I. Pyott , 61
    Chairman and Chief Exec. Officer
    3.67M21.92M
    Mr. Douglas S. Ingram J.D., Esq., 52
    Pres
    1.90M5.75M
    Mr. James M. Hindman , 54
    Chief Financial Officer and Exec. VP of Fin. & Bus. Devel.
    794.00K2.66M
    Mr. Raymond H. Diradoorian , 57
    Exec. VP of Global Technical Operations
    959.00K2.68M
    Dr. Scott M. Whitcup M.D., 56
    Chief Scientific Officer and Exec. VP of R&D
    1.24M6.86M
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders